How Long Fatigue Typically Lasts During Treatment Fatigue is most pronounced during dose escalation and commonly begins to improve once the dose stabilises, though retatrutide-specific week-by-week timeline data remain limited from published Phase 2 trial results
We'll make sure
GLP-1 effects in certain areas of the brain ultimately lead to weight loss, and in addition to the cardioprotective and renoprotective effects discussed in this article, evidence also points towards neuroprotective and other medically desirable properties ( FIGURE 1 Currently, two main classes of GLP-1 RAs are available ( In accordance with their mechanism of action, all marketed GLP-1 RAs are indicated to improve glycaemic control in people with type 2 diabetes ( Epidemiology and pathophysiology of heart failure As one of the most prevalent consequences of CVD and other cardiometabolic conditions such as diabetes and hypertension, HF remains associated with high mortality rates ( As outlined earlier, cardiometabolic diseases or risk factors such as type 2 diabetes (ClinicalTrials.gov IDs NCT04916470 and NCT04788511), it may be relevant to consider obesity-related HFpEF as a specific (sub)phenotype, whether coexisting with type 2 diabetes or not

Corporate practice of medicine doctrines in states like California, Texas, and New York restrict the ability of non-physicians to own entities that practice medicine or employ physicians in certain structures
A 2024 study published by Malhotra in The New England Journal of Medicine found that up to half of people who took Zepbound for a year saw their sleep apnea improve to a point where they might even be able to stop their CPAP therapy
It also lowered the secretion of cytokines IL-5 and IL-13 that belong to type 2 inflammation by ILC2s, suggesting that GLP-1R signaling may inhibit innate allergic immune responses in the lung [135]